Galaverni E, Pozo Navarro P, Bellini M
Departamento de Psiquiatria, Universidad de Bolonia, Bolonia, Italy.
Aten Primaria. 2005 Oct 15;36(6):312-6. doi: 10.1157/13079865.
To study the month-prevalence of any panic attacks (PA) among general practitioners' (GP) patients. To evaluate differences in terms of demographics, psychological distress and anxiety, between patients with and without PA.
One-stage cross-sectional study by the means of self-administered inventories.
Waiting room at the GP's office at the San Andres Health Centre (Murcia, Spain).
All consecutive patients attending for any reason the GP's office over one month period. 150 patients accepted to enter the study completing the assessment procedures (response rate of 60%).
Demographic characteristics, Goldberg's GHQ-12 (General Health Questionnaire) total score, STAI-Y (State and Trait Anxiety Inventory) scores, and PAAAS (Panic Attack and Anticipatory Anxiety Scale) scores. The subjects were included in the PA subgroup when showing one or more PA of any pattern (unexpected or situational, complete or subthreshold) over the last month.
The presence of PA over the last month is reported by 38% of our sample (95% IC, 30.14-45.86), with a higher rate in the age-group of 15-44 years. The PA subgroup showed State-Anxiety, Trait-Anxiety and GHQ-12 total-scores higher than those from the panicless subgroup (P<.0000); it appeared significantly younger as well.
Our study points out that any PA are a frequent issue among patients attending family-doctor's office, particularly affecting patients aged 15 to 44 years.
研究全科医生(GP)患者中任何惊恐发作(PA)的月度患病率。评估有PA和无PA患者在人口统计学、心理困扰和焦虑方面的差异。
通过自我管理问卷进行的单阶段横断面研究。
圣安德烈斯健康中心(西班牙穆尔西亚)全科医生办公室的候诊室。
在一个月期间因任何原因前往全科医生办公室就诊的所有连续患者。150名患者接受并完成了评估程序进入研究(应答率为60%)。
人口统计学特征、戈德堡GHQ-12(一般健康问卷)总分、STAI-Y(状态和特质焦虑量表)得分以及PAAAS(惊恐发作和预期焦虑量表)得分。如果受试者在过去一个月内出现一种或多种任何模式(意外或情境性、完全或亚阈值)的PA,则被纳入PA亚组。
我们样本中有38%的患者报告在过去一个月内出现过PA(95%置信区间,30.14 - 45.86),15 - 44岁年龄组的患病率更高。PA亚组的状态焦虑、特质焦虑和GHQ-12总分高于无惊恐发作亚组(P <.0000);该亚组患者也明显更年轻。
我们的研究指出,任何PA在前往家庭医生办公室就诊的患者中是一个常见问题,尤其影响15至44岁的患者。